Effect of Thickening Agents on the In Vitro Antibacterial Activity of Vancomycin Hydrochloride Powder

被引:0
|
作者
Omi, Akiko [1 ]
Doi, Nobuyuki [1 ]
Akiyama, Shigeo [2 ]
Ishioka, Taisei [3 ]
Nozawa, Akira [4 ]
机构
[1] Takasaki Univ Hlth & Welf, Lab Community Healthcare, Fac Pharm, 60 Nakaorui Machi, Takasaki, Gunma 3700033, Japan
[2] Tokyo Univ Pharm & Life Sci, Ctr Experiential Pharm Practice, Fac Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan
[3] Takasaki Univ Hlth & Welf, Dept Appl Biol Sci, Food Safety Lab, Fac Agr, 54 Nakaorui Machi, Takasaki, Gunma 3700033, Japan
[4] Kamitsuga Gen Hosp, Dept Pharm, 1-1033 Simotamachi, Kanuma, Tochigi 3228550, Japan
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 2023年 / 143卷 / 10期
关键词
vancomycin; thickening agents; xanthan gum; Clostridioides difficile; antibacterial activity; disk diffusion method;
D O I
10.1248/yakushi.23-00024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
When vancomycin hydrochloride (VCM) powder mixes with xanthan gum-based thickening agents in food, lumps or other property-related changes may occur. Previous studies have reported delayed disintegration and elution of the drug and its adsorption on to xanthan gum, which is the main ingredient of thickened food products. If the addition of thickening agents can affect the antimicrobial activity of VCM powder as previously reported, it might interfere with the treatment of Clostridioides difficile infection (CDI). In this study, we investigated the effect of the addition of xanthan gum-based thickening agents on the antibacterial activity of VCM against Clostridioides difficile in vitro. The VCM concentration at 0 min after adding 3% Tsururinko Quickly (Clinico, Tokyo) to VCM powders (Shionogi, Osaka and Meiji Seika Pharma, Tokyo) was lower than that of the control [Shionogi: 65.15 +/- 35.57%, Meiji Seika Pharma: 77.00 +/- 15.81% (mean +/- standard deviation), ** p< 0.01, Dunnet's test]. However, the VCM concentration at 30 min after the addition recovered to the control level. The drug susceptibility tests for C. difficile and Staphylococcus aureus using the disk diffusion method showed no effect of addition of 3% Tsururinko Quickly. Our in vitro evaluations showed that the addition of xanthan gum-based thickeners to VCM powders had a negligible effect on the treatment of CDI.
引用
收藏
页码:857 / 864
页数:8
相关论文
共 50 条
  • [41] In Vitro Dissolution of FIRVANQ® Compared With Reference Listed Products for Vancomycin Hydrochloride
    Patel, Shama M.
    Capila, Priya
    US PHARMACIST, 2019, 44 (12) : HS14 - HS16
  • [42] Novel nanostructured baghdadite-vancomycin scaffolds: In-vitro drug release, antibacterial activity and biocompatibility
    Bakhsheshi-Rad, H. R.
    Hamzah, E.
    Ismail, A. F.
    Aziz, M.
    Hadisi, Z.
    Kashefian, M.
    Najafinezhad, A.
    MATERIALS LETTERS, 2017, 209 : 369 - 372
  • [43] Effect of adding different thickening agents on the viscosity properties and in vitro mineral availability of infant formula
    Gonzalez-Bermudez, Carlos A.
    Frontela-Saseta, Carmen
    Lopez-Nicolas, Ruben
    Ros-Berruezo, Gaspar
    Martinez-Gracia, Carmen
    FOOD CHEMISTRY, 2014, 159 : 5 - 11
  • [44] The effect of antimicrobials agents on the antilysocyme activity of enterobacteria in vitro
    Shulga, I. S.
    Ostyakova, M. E.
    Shulga, N. N.
    Zhelyabovskaya, D. A.
    INTERNATIONAL AGROSCIENCE CONFERENCE (AGROSCIENCE-2020), 2020, 604
  • [45] 2 NEW ANTIBIOTICS - ANTIBACTERIAL ACTIVITY OF NOVOBIOCIN AND VANCOMYCIN
    FAIRBROTHER, RW
    WILLIAMS, BL
    LANCET, 1956, 271 (DEC8): : 1177 - 1179
  • [46] 5-BENZYL-2,4-DIAMINOPYRIMIDINES AS ANTIBACTERIAL AGENTS .1. SYNTHESIS AND ANTIBACTERIAL ACTIVITY IN VITRO
    ROTH, B
    BUSHBY, SRM
    HITCHINGS, GH
    FALCO, EA
    JOURNAL OF MEDICINAL & PHARMACEUTICAL CHEMISTRY, 1962, 5 (06): : 1103 - &
  • [47] Enhanced Antibacterial Activity of Vancomycin Loaded on Functionalized Polyketones
    Rampazzo, Rachele
    Vavasori, Andrea
    Ronchin, Lucio
    Riello, Pietro
    Marchiori, Martina
    Saorin, Gloria
    Beghetto, Valentina
    POLYMERS, 2024, 16 (13)
  • [48] Development of novel antibacterial agents against vancomycin-resistant bacteria
    Tanksale, A
    Pirrung, M
    FASEB JOURNAL, 2006, 20 (05): : A899 - A899
  • [49] The in vitro and in vivo antibacterial characterization of vancomycin and linezolid against vancomycin-susceptible and -resistant enterococci
    Miyazaki, S
    Fujikawa, T
    Kobayashi, I
    Matsumoto, T
    Tateda, K
    Yamaguchi, K
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (06) : 971 - 974
  • [50] Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration
    Jacqz-Aigrain, Evelyne
    Zhao, Wei
    Sharland, Mike
    van den Anker, John N.
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2013, 18 (01): : 28 - 34